Pfizer explored deal with rival Actavis: Report
September 24, 2014 at 02:31 AM EDT
Pharma giant Pfizer has been in talks for a potential acquisition of its rival Actavis in recent weeks, according to the WSJ.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.